1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Liver cancers

Lenvatinib with pembrolizumab and transarterial chemoembolization for untreated localised hepatocellular carcinoma [ID5117]

Awaiting development [GID-TA11008] Expected publication date: TBC

  • Project information
  • Project documents

29291-Lenvatinib-and-Pembrolizumab-with-TACE-for-Hepatocellular-Carcinoma-V1.0-FEB2022-NONCONF.pdf (nihr.ac.uk)